Bank of America Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $44.50

Acadia Healthcare (NASDAQ:ACHC) had its target price lowered by equities research analysts at Bank of America from $50.00 to $44.50 in a research report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Bank of America‘s target price suggests a potential upside of 10.53% from the company’s previous close.

A number of other research firms have also weighed in on ACHC. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $43.00 to $35.00 in a research report on Friday. Royal Bank of Canada restated an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a research report on Friday, January 10th. KeyCorp upgraded shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Tuesday, January 7th. Finally, TD Cowen reduced their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $64.28.

Acadia Healthcare Stock Down 1.8 %

ACHC opened at $40.26 on Friday. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $86.67. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The business’s 50-day moving average price is $42.26 and its 200-day moving average price is $52.22. The company has a market cap of $3.74 billion, a P/E ratio of 13.20, a P/E/G ratio of 1.46 and a beta of 1.30.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds have recently bought and sold shares of the business. Lindbrook Capital LLC grew its position in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC lifted its holdings in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after acquiring an additional 301 shares during the period. Signaturefd LLC boosted its position in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp increased its holdings in Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after buying an additional 454 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.